2016 Q1 Form 10-Q Financial Statement

#000153702816000021 Filed on April 28, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $22.46M $22.31M
YoY Change 0.67% 64.63%
Cost Of Revenue $12.57M $13.11M
YoY Change -4.12% 49.32%
Gross Profit $9.890M $9.200M
YoY Change 7.5% 92.87%
Gross Profit Margin 44.04% 41.24%
Selling, General & Admin $3.621M $3.827M
YoY Change -5.38% 82.76%
% of Gross Profit 36.61% 41.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.830M $4.290M
YoY Change 35.9% 25.44%
% of Gross Profit 58.95% 46.63%
Operating Expenses $3.621M $3.827M
YoY Change -5.38% 82.76%
Operating Profit $567.0K $1.532M
YoY Change -62.99% -129.47%
Interest Expense -$980.0K -$310.0K
YoY Change 216.13% -20.51%
% of Operating Profit -172.84% -20.23%
Other Income/Expense, Net
YoY Change
Pretax Income -$410.0K $1.220M
YoY Change -133.61% -121.82%
Income Tax $4.000K -$155.0K
% Of Pretax Income -12.7%
Net Earnings -$414.0K $1.375M
YoY Change -130.11% -137.11%
Net Earnings / Revenue -1.84% 6.16%
Basic Earnings Per Share $0.06
Diluted Earnings Per Share -$341.7K $0.06
COMMON SHARES
Basic Shares Outstanding 24.02M shares 24.63M shares
Diluted Shares Outstanding 24.02M shares 24.63M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.400M $11.00M
YoY Change -32.73% 254.84%
Cash & Equivalents $7.410M $11.04M
Short-Term Investments
Other Short-Term Assets $3.500M $3.900M
YoY Change -10.26% -68.03%
Inventory $2.400M $2.200M
Prepaid Expenses
Receivables $14.43M $18.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $27.74M $35.13M
YoY Change -21.05% 28.69%
LONG-TERM ASSETS
Property, Plant & Equipment $281.2M $273.9M
YoY Change 2.66% 95.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.821M $2.580M
YoY Change -29.42% 29.0%
Total Long-Term Assets $283.0M $276.5M
YoY Change 2.36% 58.0%
TOTAL ASSETS
Total Short-Term Assets $27.74M $35.13M
Total Long-Term Assets $283.0M $276.5M
Total Assets $310.8M $311.6M
YoY Change -0.28% 54.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.562M $30.01M
YoY Change -81.47% 140.1%
Accrued Expenses $7.778M $5.386M
YoY Change 44.41% 144.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $0.00
YoY Change
Total Short-Term Liabilities $13.71M $35.65M
YoY Change -61.56% 102.57%
LONG-TERM LIABILITIES
Long-Term Debt $63.10M $35.90M
YoY Change 75.77% -5.77%
Other Long-Term Liabilities $200.0K $400.0K
YoY Change -50.0% -87.5%
Total Long-Term Liabilities $63.30M $36.30M
YoY Change 74.38% -12.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.71M $35.65M
Total Long-Term Liabilities $63.30M $36.30M
Total Liabilities $77.28M $72.37M
YoY Change 6.78% 19.42%
SHAREHOLDERS EQUITY
Retained Earnings -$43.58M -$33.91M
YoY Change 28.51%
Common Stock $278.3M $274.2M
YoY Change 1.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.286M $971.0K
YoY Change 32.44%
Treasury Stock Shares 136.3K shares 85.01K shares
Shareholders Equity $233.5M $239.3M
YoY Change
Total Liabilities & Shareholders Equity $310.8M $311.6M
YoY Change -0.28% 54.05%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$414.0K $1.375M
YoY Change -130.11% -137.11%
Depreciation, Depletion And Amortization $5.830M $4.290M
YoY Change 35.9% 25.44%
Cash From Operating Activities $7.221M $5.320M
YoY Change 35.73% -212.24%
INVESTING ACTIVITIES
Capital Expenditures $5.677M $21.28M
YoY Change -73.33% 71.2%
Acquisitions
YoY Change
Other Investing Activities $650.0K $2.990M
YoY Change -78.26% 550.0%
Cash From Investing Activities -$5.029M -$18.29M
YoY Change -72.5% 52.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$126.0K 13.26M
YoY Change -100.95% -22.41%
NET CHANGE
Cash From Operating Activities $7.221M 5.320M
Cash From Investing Activities -$5.029M -18.29M
Cash From Financing Activities -$126.0K 13.26M
Net Change In Cash $2.066M 290.0K
YoY Change 612.41% -23.68%
FREE CASH FLOW
Cash From Operating Activities $7.221M $5.320M
Capital Expenditures $5.677M $21.28M
Free Cash Flow $1.544M -$15.96M
YoY Change -109.67% -7.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37628659 shares
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
Independence Contract Drilling, Inc.
CY2016Q1 icd Capital Lease Obligations Termof Contract
CapitalLeaseObligationsTermofContract
P36M
CY2015 icd Drilling Rigs Contractual Utilization
DrillingRigsContractualUtilization
0.86
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Due
OperatingandCapitalLeasesFutureMinimumPaymentsDue
911000 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Due Thereafter
OperatingandCapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Duein Five Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinFiveYears
0 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Duein Four Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinFourYears
58000 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Duein Three Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinThreeYears
125000 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Duein Two Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinTwoYears
319000 USD
CY2016Q1 icd Operatingand Capital Leases Future Minimum Payments Remainderof Fiscal Year
OperatingandCapitalLeasesFutureMinimumPaymentsRemainderofFiscalYear
409000 USD
CY2016Q1 icd Published Rig Count Decrease
PublishedRigCountDecrease
0.7
CY2015Q1 icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
7333000 USD
CY2016Q1 icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
-2552000 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10206000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7778000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8584000 USD
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5562000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18240000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14433000 USD
CY2015Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
600000 USD
CY2016Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1114000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10206000 USD
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7778000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
276948000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
278103000 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1155000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1154000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1155000 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
153000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
152000 USD
CY2015Q4 us-gaap Assets
Assets
314789000 USD
CY2016Q1 us-gaap Assets
Assets
310759000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
29337000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
27736000 USD
CY2015Q4 us-gaap Average Production Costs Per Barrel Of Oil Equivalents Boe
AverageProductionCostsPerBarrelOfOilEquivalentsBOE
37.13
CY2014Q3 us-gaap Average Production Costs Per Barrel Of Oil Equivalents Boe
AverageProductionCostsPerBarrelOfOilEquivalentsBOE
106.06
CY2016Q1 us-gaap Average Production Costs Per Barrel Of Oil Equivalents Boe
AverageProductionCostsPerBarrelOfOilEquivalentsBOE
26.19
CY2016Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
800000 USD
CY2015Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2016Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
929000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10757000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-126000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18291000 USD
CY2016Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5825000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11043000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5344000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7410000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
286000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2066000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24539937 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24539937 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24403659 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24403659 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
244000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
244000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
20774000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
21888000 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4591000 USD
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4447000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
193000 USD
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
197000 USD
CY2015Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4289000 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4289000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5825000 USD
CY2015Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
13106000 USD
CY2016Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
12567000 USD
CY2015Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
393000 USD
CY2016Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-125000 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.127
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.010
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2050000 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
629000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
221000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2016Q1 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.084
CY2015Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
-841000 USD
CY2016Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1220000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-410000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-155000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1080000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3026000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-155000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
67000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
811000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
110000 USD
CY2015Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1055000 USD
CY2016Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3807000 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-312000 USD
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-977000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
603000 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
944000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2317000 USD
CY2016Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2408000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
82052000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
77281000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314789000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310759000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18790000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13706000 USD
CY2015Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
361000 USD
CY2016Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
233000 USD
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2016Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
366000 USD
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
62708000 USD
CY2016Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
63145000 USD
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
0 USD
CY2016Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
366000 USD
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
62708000 USD
CY2016Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
63511000 USD
CY2015Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
59700000 USD
CY2016Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
59500000 USD
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
62700000 USD
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
62708000 USD
CY2016Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
63145000 USD
CY2016Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
63100000 USD
CY2016Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
27200000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13260000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5029000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5317000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
7221000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1375000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 USD
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1532000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
567000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
380000 USD
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
333000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2074000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1821000 USD
CY2015Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
161000 USD
CY2016Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21283000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5677000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3436000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3485000 USD
CY2015Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2899000 USD
CY2016Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2015Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
39760000 USD
CY2016Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
26949000 USD
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
93000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
648000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
283378000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
281202000 USD
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
73000 USD
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2016Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
10900000 USD
CY2016Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
9200000 USD
CY2016Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
7100000 USD
CY2015Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
26339000 USD
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
26937000 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
138000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43169000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43583000 USD
CY2015Q1 us-gaap Revenues
Revenues
22306000 USD
CY2016Q1 us-gaap Revenues
Revenues
22455000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3827000 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3621000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
933000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1155000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24015000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
814170 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.01
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
463413 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1277583 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.97
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.26
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.00
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
882340 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.74
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.00
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
956653 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
956653 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
104143 shares
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
74313 shares
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.00
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.88
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.73
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y1M0D
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
29830 shares
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.27
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
232737000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
233478000 USD
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2585000 USD
CY2016Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1255000 USD
CY2016Q1 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
136278 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
136278 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
136278 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1286000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1286000 USD
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24629000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24015000 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24629000 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24015000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24629000 shares

Files In Submission

Name View Source Status
0001537028-16-000021-index-headers.html Edgar Link pending
0001537028-16-000021-index.html Edgar Link pending
0001537028-16-000021.txt Edgar Link pending
0001537028-16-000021-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
icd-20160331.xml Edgar Link completed
icd-20160331.xsd Edgar Link pending
icd-20160331x10q.htm Edgar Link pending
icd-20160331x10qexx311.htm Edgar Link pending
icd-20160331x10qexx312.htm Edgar Link pending
icd-20160331x10qexx321.htm Edgar Link pending
icd-20160331x10qexx322.htm Edgar Link pending
icd-20160331_cal.xml Edgar Link unprocessable
icd-20160331_def.xml Edgar Link unprocessable
icd-20160331_lab.xml Edgar Link unprocessable
icd-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending